Pacer Advisors »

First Tracks Biotherapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.0k 432 20.83

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Altria Group Common Stock - Domestic (MO)
Comcast Corp Common Stock - Domestic (CMCSA)
Apple Common Stock - Domestic (AAPL)
Booking Holdings Common Stock - Domestic (BKNG)
Verizon Communications Common Stock - Domestic (VZ)
Pfizer Common Stock - Domestic (PFE)
At&t Common Stock - Domestic (T)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
HCA Healthcare Common Stock - Domestic (HCA)
Lowe's Cos Common Stock - Domestic (LOW)
Uber Technologies Common Stock - Domestic (UBER)
Newmont Corp Common Stock - Domestic (NEM)

View all positions for Pacer Advisors

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics